pharmaffiliates

4-((30S,33S,36S)-30-(2-(2,5-Dioxo-2,5-dihydro-1H-pyrrol-1-yl)acetamido)-33-isopropyl-26,31,34-trioxo-36-(3-ureidopropyl)-2,5,8,11,14,17,20,23-octaoxa-27,32,35-triazaheptatriacontan-37-amido)benzyl ((1S,9S)-9-ethyl-5-fluoro-9-hydroxy-4-methyl-10,13-dioxo-2,3,9,10,13,15-hexahydro-1H,12H-benzo[de]pyrano[3',4':6,7]indolizino[1,2-b]quinolin-1-yl)carbamate

In House Impurity
Print | Download pdf
Stock Status : <%stockStatus%>

<%deliveryStatus%>

Catalogue number: PA 05 1991047
Chemical name: 4-((30S,33S,36S)-30-(2-(2,5-Dioxo-2,5-dihydro-1H-pyrrol-1-yl)acetamido)-33-isopropyl-26,31,34-trioxo-36-(3-ureidopropyl)-2,5,8,11,14,17,20,23-octaoxa-27,32,35-triazaheptatriacontan-37-amido)benzyl ((1S,9S)-9-ethyl-5-fluoro-9-hydroxy-4-methyl-10,13-dioxo-2,3,9,10,13,15-hexahydro-1H,12H-benzo[de]pyrano[3',4':6,7]indolizino[1,2-b]quinolin-1-yl)carbamate

CAS Number:

2879247-31-9

Category: Fine Chemicals,pharmaceutical standards,metabolites,impurities,Intermediates,Antibody Drug Conjugate
Synonyms:

CB07-Exatecan; L-Ornithinamide, (2S)-2-[[2-(2,5-dihydro-2,5-dioxo-1H-pyrrol-1-yl)acetyl]amino]-4-(1-oxo-4,7,10,13,16,19,22,25-octaoxahexacos-1-yl)butanoyl-L-valyl-N5-(aminocarbonyl)-N-[4-[[[[[(1S,9S)-9-ethyl-5-fluoro-2,3,9,10,13,15-hexahydro-9-hydroxy-4-methyl-10,13-dioxo-1H,12H-benzo[de]pyrano[3′,4′:6,7]indolizino[1,2-b]quinolin-1-yl]amino]carbonyl]oxy]methyl]phenyl]-; (2S)-2-[[2-(2,5-Dihydro-2,5-dioxo-1H-pyrrol-1-yl)acetyl]amino]-4-(1-oxo-4,7,10,13,16,19,22,25-octaoxahexacos-1-yl)butanoyl-L-valyl-N5-(aminocarbonyl)-N-[4-[[[[[(1S,9S)-9-ethyl-5-fluoro-2,3,9,10,13,15-hexahydro-9-hydroxy-4-methyl-10,13-dioxo-1H,12H-benzo[de]pyrano[3′,4′:6,7]indolizino[1,2-b]quinolin-1-yl]amino]carbonyl]oxy]methyl]phenyl]-L-ornithinamide;

Molecular form: C71H94FN11O22
Appearance: Solid
Mol. Weight: 1472.59
Storage: 2-8°C Refrigerator
Shipping Conditions: Ambient
Applications: CB07-Exatecan is an ADC drug-Linker conjugate that can be used for the synthesis of ADCs. ADC conjugated with CB07-Exatecan and trastuzumab inhibits the growth of HER2-positive cancer cells. CB07-Exatecan can be used in cancer research

4-((30S,33S,36S)-30-(2-(2,5-Dioxo-2,5-dihydro-1H-pyrrol-1-yl)acetamido)-33-isopropyl-26,31,34-trioxo-36-(3-ureidopropyl)-2,5,8,11,14,17,20,23-octaoxa-27,32,35-triazaheptatriacontan-37-amido)benzyl ((1S,9S)-9-ethyl-5-fluoro-9-hydroxy-4-methyl-10,13-dioxo-2,3,9,10,13,15-hexahydro-1H,12H-benzo[de]pyrano[3',4':6,7]indolizino[1,2-b]quinolin-1-yl)carbamate

2879247-31-9
Reference Standards Supplier in India
| Sample COA MSDS

Enquire for 4-((30S,33S,36S)-30-(2-(2,5-Dioxo-2,5-dihydro-1H-pyrrol-1-yl)acetamido)-33-isopropyl-26,31,34-trioxo-36-(3-ureidopropyl)-2,5,8,11,14,17,20,23-octaoxa-27,32,35-triazaheptatriacontan-37-amido)benzyl ((1S,9S)-9-ethyl-5-fluoro-9-hydroxy-4-methyl-10,13-dioxo-2,3,9,10,13,15-hexahydro-1H,12H-benzo[de]pyrano[3',4':6,7]indolizino[1,2-b]quinolin-1-yl)carbamate

Order Product

Search by Keywords – Buy 2879247-31-9 | Purchase 2879247-31-9 | Order 2879247-31-9 | Enquire 2879247-31-9 | Price of 2879247-31-9 | 2879247-31-9 Cost | 2879247-31-9 Supplier | 2879247-31-9 Distributor | 2879247-31-9 Manufacturer | 2879247-31-9 Exporter

cart bucket

×

wishlist

×
Proceed